Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of infectious diseases
3.2.1.2 Growing demand for molecular diagnostics
3.2.1.3 Rising investments in life sciences research
3.2.1.4 Increasing prevalence of valvular heart diseases
3.2.2 Industry pitfalls & challenges
3.2.2.1 Regulatory and quality compliance requirements
3.2.2.2 Complexity of assay design and optimization
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 PCR tubes
5.3 PCR microplates
5.4 Cap/lids
5.5 Other products
Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Real time PCR
6.3 Digital PCR
6.4 Traditional PCR
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Research
7.3 Clinical
Chapter 8 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals and clinical diagnostic laboratories
8.3 Pharmaceutical and biotechnology companies
8.4 Academic and research institutes
8.5 Contract research organizations (CROs)
8.6 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Agilent Technologies, Inc.
10.3 Analytik Jena AG
10.4 Becton, Dickinson and Company
10.5 Bioer Technology Co., Ltd.
10.6 Bio-Rad Laboratories, Inc.
10.7 Danaher Corporation
10.8 F. Hoffmann-La Roche Ltd.
10.9 Illumina, Inc.
10.10 Merck KGaA
10.11 New England Biolabs, Inc.
10.12 Promega Corporation
10.13 QIAGEN N.V.
10.14 Takara Bio Inc.
10.15 Thermo Fisher Scientific, Inc.
